FDA orders 4 firms to stop selling unapproved codeine products

10/13/2009 | United Press International

The FDA sent warning letters prohibiting Glenmark Generics, Lehigh Valley Technologies, Cerovene and Dava International from marketing unapproved codeine sulfate tablets as a treatment for pain. The agency gave manufacturers 90 days to halt production, and distributors have 180 days to stop shipment.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC